Kidney Disease Clinical Trials

A listing of Kidney Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 157 clinical trials
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics (PK) of obinutuzumab compared with tacrolimus in participants with primary membranous nephropathy (pMN).

  • 01 Aug, 2021
  • 78 locations
Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs Distributes and Removes the Study Drug

Patients whose kidneys are no longer able to work as they should and require treatment to filter wastes from the blood (hemodialysis) are at high risk for blood clots that form in blood vessels (thrombosis) blocking blood flow that causes heart attacks, strokes, and other life-threatening conditions. BAY2976217 is under …

  • 01 Aug, 2021
  • 103 locations
Ultrasonic vs. Fluoroscopic Guided PNL in Pediatric Renal Stones

Percutaneous Nephrolithotomy (PNL) was accepted as a treatment modality for large renal stones since 1980. Although radiation exposure during PNL is within the safe limits for expert endourologist, the mutagenic hazard is still present especially in pediatric population. Therefore, employing an alternative imaging technique during PNL would be of added …

  • 01 Aug, 2021
  • 1 location
To Evaluate the Patient Tolerance Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder

The aim of the study is: To evaluate the tolerance of lanthanum polystyrene sulfonate powder in patients with end-stage renal disease (ESRD-HD) hyperphosphatemia with multiple doses and

lanthanum carbonate 500 mg
chronic kidney disease
lanthanum carbonate
renal disease
  • 01 Aug, 2021
  • 1 location
Investigating the Efficacy Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

end-stage renal disease (ESRD) who are receiving either hemodialysis (HD) or peritoneal dialysis (PD). The study will enroll patients between the ages of 2 to <18 years in two sequential cohorts

  • 24 Jul, 2021
  • 4 locations
Potential Benefits of Expanded Hemodialysis in Prevention of Sarcopenia

sarcopenia in patients with chronic kidney disease requiring hemodialysis.

  • 01 Aug, 2021
Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects

The purpose of this study is to evaluate the efficacy and safety of Sodium Zirconium Cyclosilicate (SZC), as well as the appropriateness of the dosing mechanism, in Chinese end-stage renal

  • 23 Jul, 2021
  • 21 locations
Atrasentan in Patients With IgA Nephropathy

The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA nephropathy (IgAN) at risk of progressive

renal function
  • 01 Aug, 2021
  • 58 locations
Aspirin to Target Arterial Events in Chronic Kidney Disease

This study aims to find out whether people with chronic kidney disease [CKD] should take low dose aspirin to reduce the risk of first heart attack or stroke (cardiovascular disease [CVD]). CKD

primary prevention
cardiovascular disease
glomerular filtration rate
myocardial infarction
  • 26 Jul, 2021
  • 1 location
Genetic Testing to Understand and Address Renal Disease Disparities Across the United States

The primary aim is to determine the effect of participant and provider knowledge of a positive APOL1 status and accompanying guideline based clinical decision support (CDS) on blood pressure management on change in systolic blood pressure (SBP) from baseline to 3 months after randomization among the APOL1 positive participants. Secondary …

hemoglobin a1c
antihypertensive drugs
apolipoprotein l1
  • 25 Jul, 2021
  • 9 locations